Benefits of Pneumocystis jirovecii pneumonia prevention among patients with autoimmune or inflammatory disease treated with prolonged high dose steroids. (PaRADISE)First published 24/01/2022 Last updated 23/04/2024 EU PAS number: EUPAS44554StudyOngoing
Assistance Publique - Hôpitaux de Paris (AP-HP)France First published: 01/02/2024Last updated 01/02/2024 InstitutionHospital/Clinic/Other health care facility